This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks That Could Be Trampled

Stocks in this article: HCA KMI BKU DNKN KOS

 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

5. HCA (HCA - Get Report)  

One of the largest buyouts at the time, HCA was taken private by Bain Capital and KKR (KKR) in 2006 for a total value of $33 billion. The move was the hospital chain's second takeover after a $5.1 billion management buyout in 1988. The 2006 deal was heavily financed by lenders like Bank of America (BAC), Citigroup (C) and Merrill Lynch , who helped raise $23 billion in takeover debt.

After struggling through the credit crunch, Bain and KKR returned HCA to stock markets in a $3.78 billion March 2011 IPO, the biggest U.S. private equity share offering ever. Prior to the IPO, Bain and KKR pulled a May 2010 offering to wait for markets to recover, choosing to use a $2 billion November debt offering to pay their investors a dividend.  

When HCA's offering hit markets at a price of $30 a share, Bain, KKR and Bank of America saw their initial $5 billion equity investment nearly triple as they sold roughly $1 billion worth of shares, to complement $4 billion-plus in dividends they'd pulled from the company and a remaining share stake worth over $11 billion. Stock investors haven't fared so grandly. Since its offering, HCA shares are off nearly 20% to $24.67 as of Tuesday's close, even as the company reported that its revenue grew to $32 billion and profits doubled to $2.5 billion in 2011.   

Overall, HCA is expected to earn $34 billion in 2012 revenue and $1.56 billion in profit, according to analysts polled by Bloomberg who give shares an average price target of $31.68. Seventeen analysts rate HCA shares a "buy," while eight rate the company a "hold." If the company were to see its leverage drop from present levels, it could seek to use its cash for growth acquisitions, share repurchases or special dividends, notes Bank of America Merrill Lynch analyst Kevin Fischbeck in a Mar. 1 note.  

Bain Capital holds over 89 million shares or 20.5% of the company's float, according to Bloomberg compilations of Securities and Exchange Commission filings. KKR holds a 87.5 million-plus share stake representing 20% of HCA's shares. In September 2011, Bank of America sold 80.2 million of its shares to HCA, in a repurchase move worth $1.2 billion. Meanwhile, roughly six years after their initial investment, Bain Capital and KKR are likely closing in on an exit strategy as the company's shares are expected to remain at its IPO price in coming quarters.

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,289.69 -127.16 -0.73%
S&P 500 2,011.44 -9.81 -0.49%
NASDAQ 4,670.7030 -12.7040 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs